Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 5981

1.

[Narcolepsy: electrophysiologic, biochemical, pharmacologic and immunogenetic studies].

Montplaisir J, Godbout R, Poirier G, Lapierre G.

Union Med Can. 1985 Dec;114(12):974-6. Review. French. No abstract available.

PMID:
2937192
2.

[Narcolepsy].

Billiard M.

Rev Prat. 1996 Dec 15;46(20):2428-34. Review. French.

PMID:
9035528
3.

Involvement of hypocretins/orexins in sleep disorders and narcolepsy.

Brown RE.

Drug News Perspect. 2003 Mar;16(2):75-9. Review.

PMID:
12792667
4.

The neurochemistry of awakening: findings from sleep disorder narcolepsy.

Nishino S, Sagawa Y.

Int Rev Neurobiol. 2010;93:229-55. doi: 10.1016/S0074-7742(10)93010-9. Review.

PMID:
20970008
5.

Pharmacological aspects of human and canine narcolepsy.

Nishino S, Mignot E.

Prog Neurobiol. 1997 May;52(1):27-78. Review.

PMID:
9185233
6.

Perspectives in narcolepsy research and therapy.

Mignot E.

Curr Opin Pulm Med. 1996 Nov;2(6):482-7. Review.

PMID:
9363189
7.

Coexistence of narcolepsy and Alzheimer's disease.

Scammell TE, Matheson JK, Honda M, Thannickal TC, Siegel JM.

Neurobiol Aging. 2012 Jul;33(7):1318-9. doi: 10.1016/j.neurobiolaging.2010.12.008. Epub 2011 Jan 22. Review.

PMID:
21257235
8.

The neurobiology, diagnosis, and treatment of narcolepsy.

Scammell TE.

Ann Neurol. 2003 Feb;53(2):154-66. Review.

PMID:
12557281
9.

Pharmacogenomics in the treatment of narcolepsy.

Tafti M, Dauvilliers Y.

Pharmacogenomics. 2003 Jan;4(1):23-33. Review.

PMID:
12517283
10.

The genetics of sleep disorders.

Taheri S, Mignot E.

Lancet Neurol. 2002 Aug;1(4):242-50. Review.

PMID:
12849457
11.

Investigations into the neurologic basis of narcolepsy.

Guilleminault C, Heinzer R, Mignot E, Black J.

Neurology. 1998 Feb;50(2 Suppl 1):S8-15. Review.

PMID:
9484417
12.

Genetic and familial aspects of narcolepsy.

Mignot E.

Neurology. 1998 Feb;50(2 Suppl 1):S16-22. Review.

PMID:
9484418
13.

Hypocretin/orexin and sleep: implications for the pathophysiology and diagnosis of narcolepsy.

Overeem S, Scammell TE, Lammers GJ.

Curr Opin Neurol. 2002 Dec;15(6):739-45. Review.

PMID:
12447114
14.

Paediatric narcolepsy: complexities of diagnosis.

Hood BM, Harbord MG.

J Paediatr Child Health. 2002 Dec;38(6):618-21. Review.

PMID:
12410881
15.

Narcolepsy with hypocretin/orexin deficiency, infections and autoimmunity of the brain.

Kornum BR, Faraco J, Mignot E.

Curr Opin Neurobiol. 2011 Dec;21(6):897-903. doi: 10.1016/j.conb.2011.09.003. Epub 2011 Sep 30. Review.

PMID:
21963829
16.

Hypocretins/orexins as integrators of physiological information: lessons from mutant animals.

de Lecea L, Sutcliffe JG, Fabre V.

Neuropeptides. 2002 Apr-Jun;36(2-3):85-95. Review.

PMID:
12359500
17.

New technologies for integrating genomic, environmental and trait data.

Church GM.

J Clin Sleep Med. 2011 Oct 15;7(5 Suppl):S43-4. doi: 10.5664/JCSM.1362. Review.

18.

Orexins: from neuropeptides to energy homeostasis and sleep/wake regulation.

Beuckmann CT, Yanagisawa M.

J Mol Med (Berl). 2002 Jun;80(6):329-42. Epub 2002 Apr 5. Review.

PMID:
12072908
19.

[Hypocretins/orexins and narcolepsy: from molecules to disease].

Peyron C, Charnay Y.

Rev Neurol (Paris). 2003 Nov;159(11 Suppl):6S35-41. Review. French.

PMID:
14646798
20.

Drugs to interfere with orexins (hypocretins).

Selbach O, Eriksson KS, Haas HL.

Drug News Perspect. 2003 Dec;16(10):669-81. Review.

PMID:
14747847

Supplemental Content

Support Center